Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasms × Alpelisib × Clear all

Phase

Status

Sponsor Class

INDUSTRY 3 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 22 Neoplasm Metastasis 7 Squamous Cell Carcinoma of Head and Neck 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Lymphangioma 2 Hyperglycemia 2 Head and Neck Squamous Cell Cancer 2 Vascular Malformations 1 Uveal Melanoma 1 Stomach Neoplasms 1 Solid Tumor 1 Skin Diseases, Vascular 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Meningioma 1 Melanoma 1 Lymphatic Abnormalities 1 Lymphangioma, Cystic 1 Hormone Receptor Positive Breast Carcinoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Exanthema 1

Interventions

Surveys and Questionnaires 98 Exercise 88 Blood Specimen Collection 86 Radiotherapy 60 Gemcitabine 53 Bevacizumab 52 Cisplatin 50 Standard of Care 49 Capecitabine 47 Dexamethasone 44 Cyclophosphamide 44 Carboplatin 44 Docetaxel 41 Paclitaxel 40 Interviews as Topic 40 pembrolizumab 39 Oxaliplatin 38 Methods 35 Irinotecan 35 Fluorouracil 35 Magnetic Resonance Spectroscopy 33 Therapeutics 29 Radiosurgery 28 Nivolumab 27 Drug Therapy 26 Educational Status 25 Leucovorin 22 Everolimus 21 Control Groups 21 Cognitive Behavioral Therapy 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04801966 2023-05-10

TAILOR

Peter MacCallum Cancer Centre, Australia

Phase NA Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡